MARKET WIRE NEWS

Outperform Recommendation Issued On BHVN By Leerink Partners

Source: KlickAnalytics

2026-03-03 16:15:03 ET

  • Leerink Partners analyst issues OUTPERFORM recommendation for BHVN on March 3, 2026 07:43PM ET.
  • The previous analyst recommendation was Outperform.
  • BHVN was trading at $10.67 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 18 - Buy, 7 - Hold recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendati ...
    Full story available on KlickAnalytics.com
    Biohaven Pharmaceutical Holding Company Ltd.

    NASDAQ: BHVN

    BHVN Trading

    5.98% G/L:

    $10.46 Last:

    1,593,053 Volume:

    $10.24 Open:

    mwn-alerts Ad 300

    BHVN Latest News

    BHVN Stock Data

    $1,610,213,046
    113,271,989
    1.64%
    9
    N/A
    Biotechnology & Life Sciences
    Healthcare
    US
    New Haven

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App